4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide has been researched along with Colitis Gravis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bunnett, NW; Canals, M; Carbone, SE; DiCello, JJ; Eriksson, EM; Fichna, J; McQuade, RM; Nowell, CJ; Poole, DP; Rajasekhar, P; Saito, A; Sebastian, BW; Veldhuis, NA | 1 |
1 other study(ies) available for 4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide and Colitis Gravis
Article | Year |
---|---|
Inflammation-associated changes in DOR expression and function in the mouse colon.
Topics: Animals; Benzamides; Colitis, Ulcerative; Colon; Endocytosis; Enkephalin, Leucine-2-Alanine; Enteric Nervous System; Female; Gastrointestinal Motility; Male; Mice; Mice, Inbred C57BL; Muscle Contraction; Oligopeptides; Piperazines; Receptors, Opioid, delta | 2018 |